Spinocerebellar Ataxias Clinical Trial
Official title:
Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of CAD-1883 in Adults With Spinocerebellar Ataxia (Synchrony-1)
This is a randomized, double-blind, placebo-controlled Phase 2 study evaluating oral administration of CAD-1883 in the treatment of adults with a genotypic diagnosis of Spinocerebellar Ataxia (SCA). This study offers the opportunity to understand the safety, tolerability, and efficacy of CAD-1883 in the SCA patient population.
This is a randomized, double-blind, placebo-controlled Phase 2 study evaluating oral administration of CAD-1883 in the treatment of adults with a genotypic diagnosis of SCA using multiple dose levels. The study will include multiple cohorts of 16 patients each where 12 patients will be randomized to CAD-1883 and 4 to matching placebo. Potential subjects will undergo a screening period (14 to 28 days), a baseline (Day 1) visit, and a 12-week treatment period. A follow-up visit will occur 4 weeks after the end of the treatment period. The total duration of individual subject participation may be up to 20 weeks, depending on the duration of the screening period. The study will assess safety by adverse events, vital signs, laboratory parameters (including chemistry, hematology and urinalysis); pharmacokinetics of CAD-1883; and efficacy measures by Scale for the Assessment and Rating of Ataxia (SARA), clinician/patient rating of ataxia and symptoms, patient quality of life measures and wearable sensors to capture falls and gait measurements. For planning purposes, the anticipated study completion date assumes evaluation of 3 cohorts. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05973019 -
rTMS Improves Functions in Spinocerebellar Ataxia
|
N/A | |
| Completed |
NCT04837027 -
Effect of Training on Brain Volume in Ataxia
|
N/A | |
| Completed |
NCT04595578 -
Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
|
N/A | |
| Completed |
NCT03745248 -
Aerobic Exercise, Balance Training, and Ataxia
|
N/A | |
| Completed |
NCT05951010 -
Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38
|
N/A | |
| Completed |
NCT01037777 -
RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
|
||
| Completed |
NCT00136630 -
Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
|
||
| Completed |
NCT03687190 -
Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients
|
N/A | |
| Active, not recruiting |
NCT03701399 -
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
|
Phase 3 | |
| Completed |
NCT05436262 -
Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia
|
N/A | |
| Recruiting |
NCT04231487 -
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
|
||
| Not yet recruiting |
NCT06177626 -
Impact of Exercise on Eyeblink Conditioning in Spinocerebellar Ataxias
|
N/A | |
| Recruiting |
NCT04529252 -
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
|
||
| Completed |
NCT05621200 -
Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia
|
N/A | |
| Completed |
NCT03701776 -
Ataxia and Exercise Disease Using MRI and Gait Analysis
|
N/A | |
| Completed |
NCT03120013 -
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
|
N/A | |
| Active, not recruiting |
NCT03408080 -
Open Pilot Trial of BHV-4157
|
Phase 3 | |
| Active, not recruiting |
NCT02960893 -
Trial in Adult Subjects With Spinocerebellar Ataxia
|
Phase 2/Phase 3 | |
| Completed |
NCT04153110 -
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
|
N/A | |
| Recruiting |
NCT05034172 -
Biomarker Research in Inherited Movement Disorders
|